JPWO2023182274A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2023182274A5
JPWO2023182274A5 JP2024510168A JP2024510168A JPWO2023182274A5 JP WO2023182274 A5 JPWO2023182274 A5 JP WO2023182274A5 JP 2024510168 A JP2024510168 A JP 2024510168A JP 2024510168 A JP2024510168 A JP 2024510168A JP WO2023182274 A5 JPWO2023182274 A5 JP WO2023182274A5
Authority
JP
Japan
Prior art keywords
group
formula
same
nucleic acid
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024510168A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023182274A1 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2023/010891 external-priority patent/WO2023182274A1/ja
Publication of JPWO2023182274A1 publication Critical patent/JPWO2023182274A1/ja
Publication of JPWO2023182274A5 publication Critical patent/JPWO2023182274A5/ja
Pending legal-status Critical Current

Links

JP2024510168A 2022-03-23 2023-03-20 Pending JPWO2023182274A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022047341 2022-03-23
PCT/JP2023/010891 WO2023182274A1 (ja) 2022-03-23 2023-03-20 核酸オリゴマーの製造方法

Publications (2)

Publication Number Publication Date
JPWO2023182274A1 JPWO2023182274A1 (https=) 2023-09-28
JPWO2023182274A5 true JPWO2023182274A5 (https=) 2024-12-03

Family

ID=88100953

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024510168A Pending JPWO2023182274A1 (https=) 2022-03-23 2023-03-20

Country Status (6)

Country Link
US (1) US12509485B2 (https=)
EP (1) EP4488282A4 (https=)
JP (1) JPWO2023182274A1 (https=)
KR (1) KR20240162536A (https=)
CN (1) CN118891269A (https=)
WO (1) WO2023182274A1 (https=)

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077709A (en) 1998-09-29 2000-06-20 Isis Pharmaceuticals Inc. Antisense modulation of Survivin expression
DK1149109T3 (da) 1999-02-05 2010-01-11 Ge Healthcare Bio Sciences Fremgangsmåde til afbeskyttelse af oligonukleotider
US6261840B1 (en) 2000-01-18 2001-07-17 Isis Pharmaceuticals, Inc. Antisense modulation of PTP1B expression
ES2386709T3 (es) 2004-08-26 2012-08-27 Nippon Shinyaku Co., Ltd. Compuesto de fosforamidita y método para producir un oligo-ARN
US8158775B2 (en) * 2006-02-27 2012-04-17 Nippon Shinyaku Co., Ltd. Method for detaching protecting group on nucleic acid
WO2008049085A1 (en) 2006-10-18 2008-04-24 Isis Pharmaceuticals, Inc. Antisense compounds
HUE037500T2 (hu) 2010-07-08 2018-08-28 Bonac Corp Egyszálú nukleinsav molekula a génexpresszió szabályozására
ES2527660T3 (es) 2010-08-03 2015-01-28 Bonac Corporation Molécula de ARN monocatenario que tiene esqueleto alicíclico que contiene nitrógeno
WO2013027843A1 (ja) 2011-08-25 2013-02-28 株式会社ボナック 配糖体化合物、チオエーテルの製造方法、エーテル、エーテルの製造方法、配糖体化合物の製造方法、核酸の製造方法
US9528111B2 (en) 2012-01-07 2016-12-27 Bonac Corporation Single-stranded nucleic acid molecule having amino acid backbone
EP3241902B1 (en) 2012-05-25 2018-02-28 The Regents of The University of California Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US10900034B2 (en) 2014-12-03 2021-01-26 Agilent Technologies, Inc. Guide RNA with chemical modifications
JP6787398B2 (ja) 2016-04-26 2020-11-18 住友化学株式会社 一本鎖核酸分子用モノマーの製造方法
EP3604528A4 (en) 2017-03-31 2021-01-13 Bonac Corporation CYCLIC NUCLEIC ACID MOLECULE WITH GENE EXPRESSION CONTROL FUNCTION
KR20250046363A (ko) 2017-09-19 2025-04-02 알닐람 파마슈티칼스 인코포레이티드 트랜스타이레틴(ttr) 매개 아밀로이드증을 치료하기 위한 조성물 및 방법
US20210188895A1 (en) 2017-10-13 2021-06-24 Bonac Corporation Single-stranded nucleic acid molecule, and production method therefor
TWI830718B (zh) * 2018-02-09 2024-02-01 日商住友化學股份有限公司 核酸分子之製造方法
US20230192755A1 (en) * 2020-04-14 2023-06-22 Sumitomo Chemical Company, Limited Composition containing nucleic acid oligomer
US20230242570A1 (en) * 2020-07-09 2023-08-03 Sumitomo Chemical Company, Limited Method for producing nucleic acid oligomer
JP7570858B2 (ja) 2020-09-11 2024-10-22 日鉄ステンレス株式会社 マルテンサイト系ステンレス鋼板およびマルテンサイト系ステンレス鋼板の製造方法
JP7719788B2 (ja) * 2020-09-24 2025-08-06 住友化学株式会社 核酸オリゴマーの製造方法

Similar Documents

Publication Publication Date Title
EP1527079B1 (fr) Alcoxyamines issues de nitroxydes beta-phosphores
JP2019002028A5 (https=)
BR0206352A (pt) Composição fluoroquìmica, método para tratar um substrato, substrato, e, oligÈmero fluoroquìmico
RU2014130207A (ru) Силиконовые гидрогели, содержащие n-виниламиды и гидроксиалкил(мет)акрилаты или акриламиды
JP5133606B2 (ja) 界面活性剤
CN115515993A (zh) 包含全氟化基团、可水解硅烷基团和(甲基)丙烯酰基基团的可聚合组合物和化合物
RU2012102109A (ru) Способ уменьшения вязкости углеводородных текучих сред
WO2022117389A1 (en) Method for producing a terminal-functional polymer
JP2017200882A (ja) 有機テルル化合物及びその製造方法並びにリビングラジカル重合開始剤及びそれを用いたビニル重合体の製造方法
WO2022228846A1 (en) Method for producing a terminal-functional polymer
JPWO2022203065A5 (https=)
JPWO2023182274A5 (https=)
EP2468778A1 (en) Fluoroalkyl group-containing n-substituted (meth)acrylamide compound, polymer thereof, and use thereof
JP2539505B2 (ja) アクリル官能性ハロシランの調製方法及び安定化方法
CA2897517C (fr) Utilisation de mercapto-esters methyliques en tant qu'agents de transfert de chaine
JP7098588B2 (ja) 重合性官能基含有オルガノシロキサン及び光硬化性組成物
WO2018199000A1 (ja) 有機テルル化合物及びその製造方法、リビングラジカル重合開始剤、ビニル重合体の製造方法、並びにビニル重合体
JPWO2021095875A5 (https=)
JP7061888B2 (ja) 硬化性組成物、硬化物、接着剤及び塗膜
JP2003012719A (ja) アルケニル基および硫黄原子含有ビニル系重合体
JPWO2021095874A5 (https=)
TW202502718A (zh) 含有茀骨架之(甲基)丙烯酸酯化合物、樹脂組成物及硬化物
CN101370785A (zh) 烷基咪唑酮的(甲基)丙烯酸酯基组合物
JP6044804B2 (ja) ジアリルアミン酢酸塩重合体の製造方法
JP3201267B2 (ja) ビニルフェニル基含有シラン化合物用重合禁止剤